Article
Computational Clinical Validation of Stage-conditioned Synthetic 3D FDG-PET for Alzheimer’s Disease Using Region-wise Metabolic Consistency
2026-05-21
Abstract excerpt
<title>Abstract</title> <p>Purpose Alzheimer’s disease (AD) is a progressive neurodegenerative disorder for which early diagnosis and longitudinal monitoring face two complementary constraints: ethical and practical limits on repeated Fluorodeoxyglucose Positron Emission Tomography (FDG-PET) acquisition (radiation burden, cost, scanner availability), and structural sparsity of clinically critical subgroups (e.g....
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 63c79f79-fb9a-5e27-88f8-0433cdc52b19
- DOI
- 10.21203/rs.3.rs-9652023/v1
